List view / Grid view
Filter the results
A trial has begun in the US for the ENT-01 therapy treatment of Parkinson’s, with the first patient enrolled.
A new study found that betaine supplementations given to mice reduced schizophrenic behaviours, indicating a drug target.
A new study has found an enzyme in the brains of mice models which induces Parkinson’s, suggesting future drug target.
Researchers have found a new drug target for Alzheimer’s disease after identifying a facilitating protein.
Researchers have grown identical brain organoids for the first time, opening avenues for neurological research.
Scientists expect that it will soon be possible to treat brain diseases by restoring damaged areas in the brain by mass producing neurons using stem cells...
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer's disease...
New nuclear medicine tracers could help medical researchers find a cure for Alzheimer's and other neurodegenerative diseases.
SB Drug Discovery shows the validation of fluorescence and automated electrophysiology assays designed to assess agonists, antagonists and allosteric modulators of these receptors, culminating in a high-throughput electrophysiology assay suited to assessing multiple GABAA receptor subtypes on a single assay plate.
Restoring brain cell receptors helps restore normal behaviour...